Full protection from SARS-CoV-2 brain infection and damage in susceptible transgenic mice conferred by MVA-CoV2-S vaccine candidate

Villadiego, J; García-Arriaza, J; Ramírez-Lorca, R; García-Swinburn, R; Cabello-Rivera, D; Rosales-Nieves, AE; Alvarez-Vergara, MI; Cala-Fernández, F; García-Roldán, E; López-Ogáyar, JL; Zamora, C; Astorgano, D; Albericio, G; Pérez, P; Muñoz-Cabello, AM; Pascual, A; Esteban, M; López-Barneo, J; Toledo-Aral, JJ

Villadiego, J; Toledo-Aral, JJ (通讯作者),Univ Seville, Hosp Univ Virgen Rocio, CSIC, Inst Biomed Sevilla, Seville, Spain.;Villadiego, J; Toledo-Aral, JJ (通讯作者),Univ Seville, Fac Med, Dept Fisiol Med Biofis, Seville, Spain.;Villadiego, J; Toledo-Aral, JJ (通讯作者),Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid, Spain.;García-Arriaza, J (通讯作者),CSIC, Ctr Nacl Biotecnol, Dept Biol Mol & Celular, Madrid, Spain.;García-Arriaza, J (通讯作者),Ctr Invest Biomed Red Enfermedades Infecciosas, Madrid, Spain.

NATURE NEUROSCIENCE, 2023; 26 (2): 226

Abstract

Vaccines against SARS-CoV-2 have been shown to be safe and effective but their protective efficacy against infection in the brain is yet unclear. Here......

Full Text Link